Savara Inc. (SVRA) stock analysis
SVRA · Savara Inc.
Latest recorded price: USD 4.47
Sector and industry: Healthcare · Biotechnology
Fiscal 2021 figures: free cash flow margin -15,617.9%, ROIC -72.7%. The model flags 1 risk signal for this company (1 high severity).
Similar companies in Healthcare
- Spyre Therapeutics, Inc. - Common Stock (SYRE)
- Tarsus Pharmaceuticals, Inc. - Common Stock (TARS)
- Bio-Techne Corporation (TECH)
- TG Therapeutics, Inc. (TGTX)
- Tango Therapeutics, Inc. (TNGX)
- Taysha Gene Therapies, Inc. - Common Stock (TSHA)
- Travere Therapeutics, Inc. - Common Stock (TVTX)
- UroGen Pharma Ltd. (URGN)